CClinicalTrials.gg
TerminatedNCT00610207SurgiSIS AFPUpdated Feb 2, 2016Results posted

Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft

An interventional study of Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP) in Anal Fistula and Crohn's Disease, sponsored by Cook Group Incorporated. Terminated at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-02-02.

Sponsored by Cook Group Incorporated · Not applicable, Interventional, and Treatment

Why this study was terminated
Study stopped early due to staffing changes at the site.
Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Healing anal fistulas in Crohn's patients with an anal fistula plug.

Read the detailed description

The purpose of this study is to determine whether the Surgisis anal fistula plug is effective in healing anal fistulas in patients diagnosed with Crohn's Disease.

02

Conditions studied

  • Anal Fistula
  • Crohn's Disease

Keywords

  • Anal fistula
  • fistula in ano
  • anorectal fistula
  • Crohn's Disease
03

In context

Crohn Disease

1,880 studies on the registry are indexed under Crohn Disease; 462 are open to participants now.

This study's enrollment of 21 is below the median of 66 across 1,188 interventional studies indexed under Crohn Disease.

Browse Crohn Disease studies →

Lead sponsor

Cook Group Incorporated is the lead sponsor of 73 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient is diagnosed with Crohn's Disease
  • Patient has a chronically draining anal fistula of Crohn's origin
  • Patient is 18 years old or older
  • Patient has signed an informed consent

Exclusion criteria

Exclusion Criteria:

  • Patient is pregnant or lactating
  • Patient has peri-anal drainage with originates from outside the anorectal tract
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    AFP

    Anal fistula plug placement performed during surgical procedure

    Device: Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP)

Interventions

  • DeviceSurgisis Biodesign Anal Fistula Plug (SurgiSIS AFP)

    Surgical placement of the Surgisis AFP is performed under general anesthesia

    Also known as: SurgiSIS Biodesign

06

What researchers measure

Primary outcomes

  1. Fistula Closure (Patient Based)

    Fistula closure is defined as absence of drainage at the external fistula opening.

    Time frame: 12 months

  2. Fistula Closure (Tract Based)

    Fistula closure is defined as absence of drainage at the external fistula opening. An anorectal fistula is an inflammatory tract or connection between the epithelialized surface of the anal canal and most frequently, the perianal skin or perineum. It is possible to have multiple fistula tracts present on a patient.

    Time frame: 12 months

07

Results

Posted Aug 17, 2011
Limitations and caveats
Early termination did lead to small patient numbers.

Participant flow

Participant flow — Overall Study
MilestoneBiodesign® Anal Fistula Plug
Started21
Completed18
Not completed3
Withdrew: Lost to follow-up3

Outcome measures

PrimaryFistula Closure (Patient Based)

Fistula closure is defined as absence of drainage at the external fistula opening.

Time frame:
12 months
Reported as:
Number · participants
Fistula Closure (Patient Based)
participantsBiodesign® Anal Fistula Plug
Fistula Closure (Patient Based)10
PrimaryFistula Closure (Tract Based)

Fistula closure is defined as absence of drainage at the external fistula opening. An anorectal fistula is an inflammatory tract or connection between the epithelialized surface of the anal canal and most frequently, the perianal skin or perineum. It is possible to have multiple fistula tracts present on a patient.

Time frame:
12 months
Reported as:
Number · tracts
Fistula Closure (Tract Based)
tractsBiodesign® Anal Fistula Plug
Fistula Closure (Tract Based)17

Adverse events

Collected over 12 months. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Biodesign® Anal Fistula Plug—0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Biodesign® Anal Fistula Plug
Mean40.2 (22 to 69)
Sex: Female, Male
Sex: Female, Male(Participants)Biodesign® Anal Fistula Plug
Female9
Male9
Height
Height(inches)Biodesign® Anal Fistula Plug
Mean66 (59 to 72)
Weight
Weight(pounds)Biodesign® Anal Fistula Plug
Mean148 (85 to 208)
Body Mass Index
Body Mass Index(kg/m^2)Biodesign® Anal Fistula Plug
Mean24 (14 to 37)
08

Study locations

3 sites
  • Cedars-Sinai Medical Center
    Los Angeles, California 90048, United States
  • Mount Sinai Medical Center
    New York, New York 10029, United States
  • Univeristy Hospitals Medical Center
    Cleveland, Ohio 44106, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00610207
Lead sponsor
Cook Group Incorporated
Collaborators
Cook Biotech Incorporated
Responsible party
Sponsor
First posted
Feb 7, 2008
Start date
Mar 2007
Primary completion
Apr 2010
Completion
Apr 2010
Results posted
Aug 17, 2011
Last update
Feb 2, 2016

Study contacts

Beth Moore, MD
principal investigator · Colon & Rectal Surgeons of Southern California, Mt. Sinai

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion